Neoleukin Therapeutics, Inc.
Neoleukin Therapeutics, Inc., a biopharmaceutical company, develops immunotherapies for cancer, inflammation, and autoimmunity disorders using protein design technology. The company's lead product candidate is NL-201, a de novo protein designed to mimic …
Drug Manufacturers - Specialty & Generic
US, Seattle [HQ]
Strategy & Leadership
Mergers & Acquisitions Beta
M&As
M&A Deals · Breakdown
Neoleukin Therapeutics, Inc. has no acquisition track records yet.
M&A Deals · History
Neoleukin Therapeutics, Inc. has no acquisition track records yet.